Clinical trial
A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence
NCT00142818 is registered in ClinicalTrials.gov with Kyle Kampman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Double-blind, Placebo-Controlled, Pilot Trial of the Combination of Modafinil and Naltrexone for the Treatment of Cocaine and Alcohol Dependence
- Lead sponsor
- Kyle Kampman
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- August 31, 2013
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.